Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Parkinson's disease | R-HSA-1643685 | 0 | primaquine | 26596 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | primaquine | 26596 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | primaquine | 26596 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | primaquine | 26596 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | primaquine | 26596 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | primaquine | 26596 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | naringenin | 3783 | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | naringenin | 3783 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | naringenin | 3783 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | naringenin | 3783 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | naringenin | 3783 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | naringenin | 3783 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | naringenin | 3783 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | naringenin | 3783 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | naringenin | 3783 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | naringenin | 3783 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | naringenin | 3783 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | naringenin | 3783 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | naringenin | 3783 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | naringenin | 3783 | drug-path |